Culture of urine specimens by use of chromID CPS elite medium can expedite Escherichia coli identification and reduce hands-on time in the clinical laboratory

Journal of Clinical Microbiology

Volumn 54, Issue 11, 2016, Pages 2767-2773

  Yarbrough, Melanie L ^a   Wallace, Meghan A ^a   Marshall, Cynthia ^b   Mathias, Erin ^b   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LINEZOLID; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; CULTURE MEDIUM;

ADOLESCENT; ADULT; AGAR MEDIUM; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BIOCHEMICAL ANALYSIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CULTURE MEDIUM; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; LACTOBACILLUS; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; URINE CULTURE; YEAST; CHEMISTRY; ESCHERICHIA COLI INFECTIONS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; TIME FACTOR; URINARY TRACT INFECTIONS; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; URINARY TRACT INFECTIONS; URINE; YOUNG ADULT;

EID: 84992379365     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01376-16     Document Type: Article

References (28)

1. Stamm WE, Norrby SR. 2001. Urinary tract infections: disease panorama and challenges. J Infect Dis 183(Suppl 1):S1-S4. http://dx.doi.org/10.1086/318850.
2. McCarter YS, Burd EM, Hall GS, Zervos M. 2009. Cumitech 2C: laboratory diagnosis of urinary tract infections. Coordinating ed, Sharp SE. ASM Press, Washington, DC.
3. Garcia E, Ali AM, Soles RM, Lewis DG. 2015. The American Society for Clinical Pathology's 2014 vacancy survey of medical laboratories in the United States. Am J Clin Pathol 144:432-443. http://dx.doi.org/10.1309/AJCPN7G0MXMSTXCD.
4. Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF, Infectious Diseases Society of America. 2013. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 57(Suppl 3):S139-S170. http://dx.doi.org/10.1093/cid/cit578.
5. Pence MA, McElvania TeKippe E, Wallace MA, Burnham CA. 2014. Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur J Clin Microbiol Infect Dis 33:1703-1712. http://dx.doi.org/10.1007/s10096-014-2115-x.
6. Ford BA, Burnham CA. 2013. Optimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper. J Clin Microbiol 51:1412-1420. http://dx.doi.org/10.1128/JCM.01803-12.
7. McElvania Tekippe E, Shuey S, Winkler DW, Butler MA, Burnham CA. 2013. Optimizing identification of clinically relevant Gram-positive organisms by use of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol 51: 1421-1427. http://dx.doi.org/10.1128/JCM.02680-12.
8. McElvania TeKippe E, Burnham CA. 2014. Evaluation of the Bruker Biotyper and Vitek MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens. Eur J Clin Microbiol Infect Dis 33:2163-2171. http://dx.doi.org/10.1007/s10096-014-2183-y.
9. Ling H, Yuan Z, Shen J, Wang Z, Xu Y. 2014. Accuracy of matrixassisted laser desorption ionization-time of flight mass spectrometry for identification of clinical pathogenic fungi: A meta-analysis. J Clin Microbiol 52:2573-2582. http://dx.doi.org/10.1128/JCM.00700-14.
10. Gonzalez MD, Weber CJ, Burnham CA. 2016. Rapid identification of microorganisms from positive blood cultures by testing early growth on solid media using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Diagn Microbiol Infect Dis 85:133-135. http://dx.doi.org/10.1016/j.diagmicrobio.2016.02.018.
11. Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC. 2014. Multicenter evaluation of the Vitek® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis 33:337-346. http://dx.doi.org/10.1007/s10096-013-1961-2.
12. Richter SS, Sercia L, Branda JA, Burnham CA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Rychert JA, Westblade LF, Procop GW. 2013. Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the Vitek MS system. Eur J Clin Microbiol Infect Dis 32:1571-1578. http://dx.doi.org/10.1007/s10096-013-1912-y.
13. Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA. 2013. Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J Clin Microbiol 51:2225-2231. http://dx.doi.org/10.1128/JCM.00682-13.
14. Westblade LF, Garner OB, MacDonald K, Bradford C, Pincus DH, Mochon AB, Jennemann R, Manji R, Bythrow M, Lewinski MA, Burnham CA, Ginocchio CC. 2015. Assessment of reproducibility of matrixassisted laser desorption ionization-time of flight mass spectrometry for bacterial and yeast identification. J Clin Microbiol 53:2349-2352. http://dx.doi.org/10.1128/JCM.00187-15.
15. Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA. 2013. Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol 51:2267-2272. http://dx.doi.org/10.1128/JCM.00680-13.
16. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. 2015. Urinary tract infections: epidemiology, mechanisms of infection, and treatment options. Nat Rev Microbiol 13:269-284. http://dx.doi.org/10.1038/nrmicro3432.
17. Aspevall O, Osterman B, Dittmer R, Stén L, Lindbäck E, Forsum U. 2002. Performance of four chromogenic urine culture media after one or two days of incubation compared with reference media. J Clin Microbiol 40:1500-1503. http://dx.doi.org/10.1128/JCM.40.4.1500-1503.2002.
18. Chang JC, Chien ML, Chen HM, Yan JJ, Wu JJ. 2008. Comparison of CPS ID 3 and CHROMagar Orientation chromogenic agars with standard biplate technique for culture of clinical urine samples. J Microbiol Immunol Infect 41:422-427.
19. Payne M, Roscoe D. 2015. Evaluation of two chromogenic media for the isolation and identification of urinary tract pathogens. Eur J Clin Microbiol Infect Dis 34:303-308. http://dx.doi.org/10.1007/s10096-014-2235-3.
20. Rigaill J, Verhoeven PO, Mahinc C, Jeraiby M, Grattard F, Fonsale N, Pozzetto B, Carricajo A. 2015. Evaluation of new bioMérieux chromogenic CPS media for detection of urinary tract pathogens. J Clin Microbiol 53:2701-2702. http://dx.doi.org/10.1128/JCM.00941-15.
21. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement. CLSI document M100-S26. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial disk susceptibility tests; approved standard- twelfth edition. CLSI document M02-A12. Clinical and Laboratory Standards Institute, Wayne, PA.
23. D'Souza HA, Campbell M, Baron EJ. 2004. Practical bench comparison of BBL CHROMagar orientation and standard two-plate media for urine cultures. J Clin Microbiol 42:60-64. http://dx.doi.org/10.1128/JCM.42.1 .60-64.2004.
24. Ciragil P, Gul M, Aral M, Ekerbicer H. 2006. Evaluation of a new chromogenic medium for isolation and identification of common urinary tract pathogens. Eur J Clin Microbiol Infect Dis 25:108-111. http://dx.doi.org/10.1007/s10096-006-0103-5.
25. Perry JD, Butterworth LA, Nicholson A, Appleby MR, Orr KE. 2003. Evaluation of a new chromogenic medium, Uriselect 4, for the isolation and identification of urinary tract pathogens. J Clin Pathol 56:528-531. http://dx.doi.org/10.1136/jcp.56.7.528.
26. Manickam K, Karlowsky JA, Adam H, Lagacé-Wiens PR, Rendina A, Pang P, Murray BL, Alfa MJ. 2013. CHROMagar orientation medium reduces urine culture workload. J Clin Microbiol 51:1179-1183. http://dx.doi.org/10.1128/JCM.02877-12.
27. Burnham CA, Dunne WM, Jr, Greub G, Novak SM, Patel R. 2013. Automation in the clinical microbiology laboratory. Clin Chem 59:1696-1702. http://dx.doi.org/10.1373/clinchem.2012.201038.
28. Ohkusu K. 2000. Cost-effective and rapid presumptive identification of gram-negative bacilli in routine urine, pus, and stool cultures: evaluation of the use of CHROMagar orientation medium in conjunction with simple biochemical tests. J Clin Microbiol 38:4586-4592.